About
MedAlliance Swiss Medical Technology is a privately-owned company based in Nyon, Switzerland, with additional facilities in the USA, UK, Singapore, and Germany. Founded in 2008, the company employs between 51 and 200 people and generates annual revenues estimated between $5 million and $25 million, with some sources indicating figures up to $100 million. The company specializes in developing and commercializing drug-device combination products, particularly drug-eluting balloons (DEBs) for treating coronary and peripheral artery diseases. Their flagship product, the SELUTION SLR™ drug-eluting balloon catheter, utilizes microreservoir technology for sustained sirolimus release, enhancing drug delivery in cardiovascular procedures. MedAlliance's products are designed for use in various cardiovascular and endovascular interventions, providing therapeutic benefits without the need for permanent stents. In 2023, MedAlliance was acquired by Cordis, a Johnson & Johnson company, in a significant deal valued at approximately $1.135 billion.
Technologies
Keywords
Company Information
- Employees68
- Founded2008
- Total Funding$50000000
Location
5 Rue de Rive, Nyon, Vaud, Switzerland, 1260
